As an R&D Director with around 20 years of industry experience in oncology and immuno-oncology drug research and development, Jutta brings comprehensive expertise in discovery and clinical development of antibodies, ADCs and cell-based therapies for solid tumors and hematologic malignancies.

Her deep knowledge of cell biology, pharmacology, translational medicine and clinical biomarker development contributes advancing our ADC programs from target validation to clinical POC.